The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells

DNA Repair

Volumn 11, Issue 5, 2012, Pages 488-501

  Bailey, Arnold D ^a   Gray, Lucas T ^a   Pavelitz, Thomas ^a   Newman, John C ^b   Horibata, Katsuyoshi ^c   Tanaka, Kiyoji ^c   Weiner, Alan M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cockayne; CSB; Immunity; Interferon; PiggyBac; TCR

Indexed keywords

HYBRID PROTEIN; INTERFERON; PIGGYBAC PROTEIN; PROTEIN DERIVATIVE; SOMATOMEDIN; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; COCKAYNE SYNDROME; CYTOTOXICITY; DNA REPAIR; DOWN REGULATION; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MICROARRAY ANALYSIS; NULL CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ULTRAVIOLET RADIATION;

CELL LINE; COCKAYNE SYNDROME; DEAD-BOX RNA HELICASES; DNA HELICASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; HUMANS; IMMUNITY, INNATE; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERONS; MUTANT CHIMERIC PROTEINS; STAT1 TRANSCRIPTION FACTOR; ULTRAVIOLET RAYS;

MYA; PRIMATES;

EID: 84860235841     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2012.02.004     Document Type: Article

References (68)

1. Beerens N., Hoeijmakers J.H., Kanaar R., Vermeulen W., Wyman C. The CSB protein actively wraps DNA. J. Biol. Chem. 2005, 280:4722-4729.
2. Citterio E., Van Den Boom V., Schnitzler G., Kanaar R., Bonte E., Kingston R.E., Hoeijmakers J.H., Vermeulen W. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor. Mol. Cell Biol. 2000, 20:7643-7653.
3. Newman J.C., Bailey A.D., Weiner A.M. Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9613-9618.
4. Nardo T., Oneda R., Spivak G., Vaz B., Mortier L., Thomas P., Orioli D., Laugel V., Stary A., Hanawalt P.C., Sarasin A., Stefanini M. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6209-6214.
5. Groisman R., Kuraoka I., Chevallier O., Gaye N., Magnaldo T., Tanaka K., Kisselev A.F., Harel-Bellan A., Nakatani Y. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes Dev. 2006, 20:1429-1434.
6. Anindya R., Mari P.O., Kristensen U., Kool H., Giglia-Mari G., Mullenders L.H., Fousteri M., Vermeulen W., Egly J.M., Svejstrup J.Q. A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair. Mol. Cell 2010, 38:637-648.
7. Harreman M., Taschner M., Sigurdsson S., Anindya R., Reid J., Somesh B., Kong S.E., Banks C.A., Conaway R.C., Conaway J.W., Svejstrup J.Q. Distinct ubiquitin ligases act sequentially for RNA polymerase II polyubiquitylation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20705-20710.
8. Laugel V., Dalloz C., Durand M., Sauvanaud F., Kristensen U., Vincent M.C., Pasquier L., Odent S., Cormier-Daire V., Gener B., Tobias E.S., Tolmie J.L., Martin-Coignard D., Drouin-Garraud V., Heron D., Journel H., Raffo E., Vigneron J., Lyonnet S., Murday V., Gubser-Mercati D., Funalot B., Brueton L., Sanchez Del Pozo J., Munoz E., Gennery A.R., Salih M., Noruzinia M., Prescott K., Ramos L., Stark Z., Fieggen K., Chabrol B., Sarda P., Edery P., Bloch-Zupan A., Fawcett H., Pham D., Egly J.M., Lehmann A.R., Sarasin A., Dollfus H. Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum. Mutat. 2010, 31:113-126.
9. Ito S., Kuraoka I., Chymkowitch P., Compe E., Takedachi A., Ishigami C., Coin F., Egly J.M., Tanaka K. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol. Cell 2007, 26:231-243.
10. Fousteri M., Mullenders L.H. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008, 18:73-84.
11. Gray L.T., Weiner A.M. Ubiquitin recognition by the Cockayne syndrome group B protein: binding will set you free. Mol. Cell 2010, 38:621-622.
12. Filippi S., Latini P., Frontini M., Palitti F., Egly J.M., Proietti-De-Santis L. CSB protein is (a direct target of HIF-1 and) a critical mediator of the hypoxic response. EMBO J. 2008, 27:2545-2556.
13. Horibata K., Iwamoto Y., Kuraoka I., Jaspers N.G., Kurimasa A., Oshimura M., Ichihashi M., Tanaka K. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15410-15415.
14. Hashimoto S., Suga T., Kudo E., Ihn H., Uchino M., Tateishi S. Adult-onset neurological degeneration in a patient with Cockayne syndrome and a null mutation in the CSB gene. J. Invest. Dermatol. 2008, 128:1597-1599.
15. Laugel V., Dalloz C., Stary A., Cormier-Daire V., Desguerre I., Renouil M., Fourmaintraux A., Velez-Cruz R., Egly J.M., Sarasin A., Dollfus H. Deletion of 5' sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome. Eur. J. Hum. Genet. 2008, 16:320-327.
16. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 1992, 42:68-84.
17. Colella S., Nardo T., Botta E., Lehmann A.R., Stefanini M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Hum. Mol. Genet. 2000, 9:1171-1175.
18. Newman J.C., Bailey A.D., Fan H.Y., Pavelitz T., Weiner A.M. An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome. PLoS Genet. 2008, 4:e1000031.
19. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
20. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250.
21. Maziere C., Dantin F., Dubois F., Santus R., Maziere J. Biphasic effect of UVA radiation on STAT1 activity and tyrosine phosphorylation in cultured human keratinocytes. Free Radic. Biol. Med. 2000, 28:1430-1437.
22. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., Levy D.E., Muller M., Decker T. Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 2001, 20:91-100.
23. Yu A., Fan H.Y., Liao D., Bailey A.D., Weiner A.M. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes. Mol. Cell 2000, 5:801-810.
24. Spivak G., Hanawalt P.C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst) 2006, 5:13-22.
25. Ares M., Chung J.S., Giglio L., Weiner A.M. Distinct factors with Sp1 and NF-A specificities bind to adjacent functional elements of the human U2 snRNA gene enhancer. Genes Dev. 1987, 1:808-817.
26. Vermeulen W., Rademakers S., Jaspers N.G., Appeldoorn E., Raams A., Klein B., Kleijer W.J., Hansen L.K., Hoeijmakers J.H. A temperature-sensitive disorder in basal transcription and DNA repair in humans. Nat. Genet. 2001, 27:299-303.
27. Horibata K., Saijo M., Bay M.N., Lan L., Kuraoka I., Brooks P.J., Honma M., Nohmi T., Yasui A., Tanaka K. Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex. Genes Cells 2011, 16:101-114.
28. Itoh T., Yamaizumi M. UVs syndrome: establishment and characterization of fibroblastic cell lines transformed with simian virus 40 DNA. J. Invest. Dermatol. 2000, 114:101-106.
29. Newman J.C., Weiner A.M. L2L: a simple tool for discovering the hidden significance in microarray expression data. Genome Biol. 2005, 6:R81.
30. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
31. Cheon H., Stark G.R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9373-9378.
32. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
33. Chatterjee-Kishore M., Wright K.L., Ting J.P., Stark G.R. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. Embo J. 2000, 19:4111-4122.
34. Cheon H., Yang J., Stark G.R. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J. Interferon Cytokine Res. 2011, 31:33-40.
35. Hou Y.C., Liou K.T., Chern C.M., Wang Y.H., Liao J.F., Chang S., Chou Y.H., Shen Y.C. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-kappaB and STAT-1 activation. Phytomedicine 2010, 17:963-973.
36. Stephanou A., Scarabelli T.M., Brar B.K., Nakanishi Y., Matsumura M., Knight R.A., Latchman D.S. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J. Biol. Chem. 2001, 276:28340-28347.
37. Lim C.P., Cao X. Structure, function, and regulation of STAT proteins. Mol. Biosyst. 2006, 2:536-550.
38. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22:41-47.
39. Gerlier D., Avice T. Use of an automatic cell harvester in a cellular radioimmunoassay. J. Immunol. Methods 1984, 75:159-166.
40. Jiang L.J., Zhang N.N., Ding F., Li X.Y., Chen L., Zhang H.X., Zhang W., Chen S.J., Wang Z.G., Li J.M., Chen Z., Zhu J. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:1897-1902.
41. Sauter D., Specht A., Kirchhoff F. Tetherin: holding on and letting go. Cell 2010, 141:392-398.
42. Evans D.T., Serra-Moreno R., Singh R.K., Guatelli J.C. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 2010, 18:388-396.
43. van Boxel-Dezaire A.H., Stark G.R. Cell type-specific signaling in response to IFN-β. Curr. Top. Microbiol. Immunol. 2007, 316:119-154.
44. van der Pluijm I., Garinis G.A., Brandt R.M., Gorgels T.G., Wijnhoven S.W., Diderich K.E., de Wit J., Mitchell J.R., van Oostrom C., Beems R., Niedernhofer L.J., Velasco S., Friedberg E.C., Tanaka K., van Steeg H., Hoeijmakers J.H., van der Horst G.T. Impaired genome maintenance suppresses the growth hormone - insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biol. 2007, 5:e2.
45. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., van Leeuwen W., Theil A.F., Vermeulen W., van der Horst G.T., Meinecke P., Kleijer W.J., Vijg J., Jaspers N.G., Hoeijmakers J.H. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444:1038-1043.
46. Moserle L., Indraccolo S., Ghisi M., Frasson C., Fortunato E., Canevari S., Miotti S., Tosello V., Zamarchi R., Corradin A., Minuzzo S., Rossi E., Basso G., Amadori A. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res. 2008, 68:5658-5668.
47. Dauer D.J., Ferraro B., Song L., Yu B., Mora L., Buettner R., Enkemann S., Jove R., Haura E.B. Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005, 24:3397-3408.
48. Browne E.P., Wing B., Coleman D., Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J. Virol. 2001, 75:12319-12330.
49. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15623-15628.
50. Sawyer S.L., Emerman M., Malik H.S. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 2007, 3:e197.
51. Dong B., Zhou Q., Zhao J., Zhou A., Harty R.N., Bose S., Banerjee A., Slee R., Guenther J., Williams B.R., Wiedmer T., Sims P.J., Silverman R.H. Phospholipid scramblase 1 potentiates the antiviral activity of interferon. J. Virol. 2004, 78:8983-8993.
52. Rivieccio M.A., Suh H.S., Zhao Y., Zhao M.L., Chin K.C., Lee S.C., Brosnan C.F. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 2006, 177:4735-4741.
53. Feschotte C. Transposable elements and the evolution of regulatory networks. Nat. Rev. Genet. 2008, 9:397-405.
54. Garinis G.A., Uittenboogaard L.M., Stachelscheid H., Fousteri M., van Ijcken W., Breit T.M., van Steeg H., Mullenders L.H., van der Horst G.T., Bruning J.C., Niessen C.M., Hoeijmakers J.H., Schumacher B. Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity. Nat. Cell Biol. 2009, 11:604-615.
55. Garinis G.A., van der Horst G.T., Vijg J., Hoeijmakers J.H. DNA damage and ageing: new-age ideas for an age-old problem. Nat. Cell Biol. 2008, 10:1241-1247.
56. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 2003, 3:900-911.
57. Gough D.J., Levy D.E., Johnstone R.W., Clarke C.J. IFNγ signaling-does it mean JAK-STAT?. Cytokine Growth Factor Rev. 2008, 19:383-394.
58. Chen L.L., Yang L., Carmichael G.G. Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell Cycle 2010, 9:3552-3564.
59. Brooks P.J., Cheng T.F., Cooper L. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?. DNA Repair (Amst) 2008, 7:834-848.
60. Gall A., Treuting P., Elkon K.B., Loo Y.M., Gale M., Barber G.N., Stetson D.B. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
61. Alic N., Hoddinott M.P., Vinti G., Partridge L. Lifespan extension by increased expression of the Drosophila homologue of the IGFBP7 tumour suppressor. Aging Cell 2011, 10:137-147.
62. Sykora P., Wilson D.M., Bohr V.A. Repair of persistent strand breaks in the mitochondrial genome. Mech. Ageing Dev. 2011, Nov 28. [Epub ahead of print].
63. Gough S.M., Slape C.I., Aplan P.D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011, 118:6247-6257.
64. Ghannam G., Takeda A., Camarata T., Moore M.A., Viale A., Yaseen N.R. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells. J. Biol. Chem. 2004, 279:866-875.
65. Takeda A., Sarma N.J., Abdul-Nabi A.M., Yaseen N.R. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J. Biol. Chem. 2010, 285:16248-16257.
66. Cordaux R., Udit S., Batzer M.A., Feschotte C. Birth of a chimeric primate gene by capture of the transposase gene from a mobile element. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8101-8106.
67. Fnu S., Williamson E.A., De Haro L.P., Brenneman M., Wray J., Shaheen M., Radhakrishnan K., Lee S.H., Nickoloff J.A., Hromas R. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:540-545.
68. Beck B.D., Lee S.S., Williamson E., Hromas R.A., Lee S.H. Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair. Biochemistry 2011, 50:4360-4370.